lunes, 12 de octubre de 2009
Comisión Europea "pone en la mira" a Rambaxy, Novartis/Sandoz, Sanofi-Aventis y Teva...
The commission also conducted surprise visits in France at Sanofi-Aventis SA, Teva Pharmaceutical Industries Ltd.Novartis AG unit, spokespeople for the companies said yesterday. The commission, the EU’s antitrust regulator, said the companies may have abused their dominant market positions or engaged in “restrictive business practices.” and a
Más...
Etiquetas:
Agrupaciones,
Genéricos,
Novartis,
Patentes,
Sandoz,
SanofiAventis,
Teva
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario